Tale of the two CEOs at Apria
By HME News Staff
Updated Thu March 15, 2012
LAKE FOREST, Calif. - Apria Healthcare plans to give its two business units more freedom, the provider announced this week.
Apria has named Daniel Starck CEO of its respiratory/HME operating unit, and Daniel Greenleaf CEO of its Coram Specialty Infusion Services operating unit.
Norman Payson will continue to serve as CEO and executive chairman of Apria Healthcare Group, the parent company of both operating units. He will also provide strategic oversight to Starck and Greenleaf.
"Our goal is to enable the management teams of both operating units to unlock the value of their respective organizations over the long term," Payson stated in a release.
Starck most recently served as CEO of CorVel Corp., a national provider of workers' compensation solutions. Prior to that, he held positions at Apria and another company.
Greenleaf joined Apria as president of Coram in 2008. For the past 18 months, Greenleaf has served as COO of Apria Healthcare and president/CEO of Coram.
"In his recent combined role, Dan Greenleaf continued to lead our Coram division to achieve significant revenue growth in 2011 even though he had the additional responsibility of the respiratory therapy division," Payson stated.
Apria Healthcare acquired Coram for $350 million in late 2007.
Apria Healthcare Group has about 540 locations nationwide and more than $2 billion in annual net revenues, according to the release.
Comments